10-K Filing

ENVERIC BIOSCIENCES, INC. CIK: 890821 FY 2022

Filing Information

Form Type	10-K
Accession Number	`0001493152-23-010431`
Period End Date	20221231
Filing Date	20230331
Fiscal Year	2022
Fiscal Period	FY
XBRL Instance	form10-k_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 77 Income Statement 44 Cash Flow Statement 84 Stockholders Equity 38

Balance Sheet 77 line items

Line Item	Tag	Value	Unit	Period
Cash	`Cash`	$17.72M	USD	Point-in-time
Cash	`Cash`	$17.36M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$708.05K	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$380.84K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$18.43M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$17.74M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$294.43K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$677.49K	USD	Point-in-time
Right-of-use operating lease asset	`OperatingLeaseRightOfUseAsset`	$176.30K	USD	Point-in-time
Right-of-use operating lease asset	`OperatingLeaseRightOfUseAsset`	$63.82K	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$6.92M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$379.69K	USD	Point-in-time
Goodwill	`Goodwill`	-	USD	Point-in-time
Goodwill	`Goodwill`	-	USD	Point-in-time
Goodwill	`Goodwill`	$1.59M	USD	Point-in-time
Total other assets	`AssetsNoncurrent`	$1.12M	USD	Point-in-time
Total other assets	`AssetsNoncurrent`	$8.98M	USD	Point-in-time
Total assets	`Assets`	$19.55M	USD	Point-in-time
Total assets	`Assets`	$26.72M	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	20.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	20.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	20.00M	shares	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$463.27K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$683.39K	USD	Point-in-time
Accrued liabilities	`AccruedLiabilitiesCurrent`	$1.71M	USD	Point-in-time
Accrued liabilities	`AccruedLiabilitiesCurrent`	$1.29M	USD	Point-in-time
Current portion of right-of-use operating lease obligation	`OperatingLeaseLiabilityCurrent`	$63.82K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Current portion of right-of-use operating lease obligation	`OperatingLeaseLiabilityCurrent`	$107.44K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Investment option liability	`OtherLiabilitiesCurrent`	-	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Investment option liability	`OtherLiabilitiesCurrent`	$851.01K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	2.08M	shares	Point-in-time
Warrant liability	`WarrantLiabilitiesCurrent`	$185.22K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	651,921.00	shares	Point-in-time
Warrant liability	`WarrantLiabilitiesCurrent`	$653.67K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	2.08M	shares	Point-in-time
Derivative liability	`DerivativeLiabilitiesCurrent`	-	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	651,921.00	shares	Point-in-time
Derivative liability	`DerivativeLiabilitiesCurrent`	$727.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.74M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$4.00M	USD	Point-in-time
Non-current portion of right-of-use operating lease obligation	`OperatingLeaseLiabilityNoncurrent`	-	USD	Point-in-time
Non-current portion of right-of-use operating lease obligation	`OperatingLeaseLiabilityNoncurrent`	$68.86K	USD	Point-in-time
Deferred tax liability	`DeferredIncomeTaxLiabilities`	$1.61M	USD	Point-in-time
Deferred tax liability	`DeferredIncomeTaxLiabilities`	-	USD	Point-in-time
Total non-current liabilities	`LiabilitiesNoncurrent`	$1.68M	USD	Point-in-time
Total non-current liabilities	`LiabilitiesNoncurrent`	-	USD	Point-in-time
Total liabilities	`Liabilities`	$4.00M	USD	Point-in-time
Total liabilities	`Liabilities`	$4.41M	USD	Point-in-time
Commitments and contingencies (Note 9)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 9)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Series C redeemable preferred stock, $0.01 par value, 100,000 shares authorized, and 52,684.548 and 0 shares issued and outstanding as of December 31, 2022 and 2021, respectively	`TemporaryEquityCarryingAmountAttributableToParent`	-	USD	Point-in-time
Series C redeemable preferred stock, $0.01 par value, 100,000 shares authorized, and 52,684.548 and 0 shares issued and outstanding as of December 31, 2022 and 2021, respectively	`TemporaryEquityCarryingAmountAttributableToParent`	-	USD	Point-in-time
Redeemable non-controlling interest	`RedeemableNoncontrollingInterestEquityCarryingAmount`	-	USD	Point-in-time
Redeemable non-controlling interest	`RedeemableNoncontrollingInterestEquityCarryingAmount`	$885.03K	USD	Point-in-time
Total temporary equity	`TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests`	-	USD	Point-in-time
Total temporary equity	`TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests`	$885.03K	USD	Point-in-time
Preferred stock, $0.01 par value, 20,000,000 shares authorized; Series B preferred stock, $0.01 par value, 3,600,000 shares authorized, 0 shares issued and outstanding as of December 31, 2022 and 2021, respectively	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.01 par value, 20,000,000 shares authorized; Series B preferred stock, $0.01 par value, 3,600,000 shares authorized, 0 shares issued and outstanding as of December 31, 2022 and 2021, respectively	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.01 par value, 100,000,000 shares authorized, 2,078,271 and 651,921 shares issued and outstanding as of December 31, 2022 and 2021, respectively	`CommonStockValue`	$6.52K	USD	Point-in-time
Common stock, $0.01 par value, 100,000,000 shares authorized, 2,078,271 and 651,921 shares issued and outstanding as of December 31, 2022 and 2021, respectively	`CommonStockValue`	$20.78K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$83.07M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$94.40M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-79.21M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-60.74M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-536.73K	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-30.80K	USD	Point-in-time
Total shareholders equity	`StockholdersEquity`	$22.31M	USD	Point-in-time
Total shareholders equity	`StockholdersEquity`	$3.42M	USD	Point-in-time
Total shareholders equity	`StockholdersEquity`	$14.67M	USD	Point-in-time
Total liabilities, temporary equity, and shareholders equity	`LiabilitiesAndStockholdersEquity`	$19.55M	USD	Point-in-time
Total liabilities, temporary equity, and shareholders equity	`LiabilitiesAndStockholdersEquity`	$26.72M	USD	Point-in-time

Income Statement 44 line items

Line Item	Tag	Value	Unit	Period
General and administrative	`GeneralAndAdministrativeExpense`	$11.61M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$20.50M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$8.03M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$4.79M	USD	Annual
Impairment of intangible assets and goodwill	`GoodwillAndIntangibleAssetImpairment`	$7.45M	USD	Annual
Impairment of intangible assets and goodwill	`GoodwillAndIntangibleAssetImpairment`	$38.68M	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	$656.64K	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	$327.91K	USD	Annual
Total operating expenses	`OperatingCostsAndExpenses`	$64.62M	USD	Annual
Total operating expenses	`OperatingCostsAndExpenses`	$27.42M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-27.42M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-64.62M	USD	Annual
Inducement expense	`InducementExpense`	-	USD	Annual
Inducement expense	`InducementExpense`	$1.13M	USD	Annual
Change in fair value of warrant liabilities	`FairValueAdjustmentOfWarrants`	$-9.33M	USD	Annual
Change in fair value of warrant liabilities	`FairValueAdjustmentOfWarrants`	$-4.32M	USD	Annual
Change in fair value of investment option liability	`GainLossOnInvestments`	$3.47M	USD	Annual
Change in fair value of investment option liability	`GainLossOnInvestments`	-	USD	Annual
Change in fair value of derivative liability	`DerivativeGainLossOnDerivativeNet`	-	USD	Annual
Change in fair value of derivative liability	`DerivativeGainLossOnDerivativeNet`	$-325.00K	USD	Annual
Interest expense	`InterestExpense`	$10.32K	USD	Annual
Interest expense	`InterestExpense`	$5.25K	USD	Annual
Total other income	`NonoperatingIncomeExpense`	$8.19M	USD	Annual
Total other income	`NonoperatingIncomeExpense`	$7.46M	USD	Annual
Net loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-19.96M	USD	Annual
Net loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-56.43M	USD	Annual
Income tax benefit	`IncomeTaxExpenseBenefit`	$-7.45M	USD	Annual
Income tax benefit	`IncomeTaxExpenseBenefit`	$-1.49M	USD	Annual
Net loss	`NetIncomeLoss`	$-18.47M	USD	Annual
Net loss	`NetIncomeLoss`	$-48.98M	USD	Annual
Less preferred dividends attributable to non-controlling interest	`PreferredStockDividendsIncomeStatementImpact`	-	USD	Annual
Less preferred dividends attributable to non-controlling interest	`PreferredStockDividendsIncomeStatementImpact`	$33.01K	USD	Annual
Less deemed dividends attributable to accretion of embedded derivative at redemption value	`TemporaryEquityAccretionToRedemptionValueAdjustment`	$295.98K	USD	Annual
Less deemed dividends attributable to accretion of embedded derivative at redemption value	`TemporaryEquityAccretionToRedemptionValueAdjustment`	-	USD	Annual
Net loss attributable to shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-48.98M	USD	Annual
Net loss attributable to shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-18.80M	USD	Annual
Foreign currency translation	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$150.47K	USD	Annual
Foreign currency translation	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-505.93K	USD	Annual
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-19.31M	USD	Annual
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-48.83M	USD	Annual
Net loss per share - basic and diluted	`EarningsPerShareBasic`	$-103.69	USD	Annual
Net loss per share - basic and diluted	`EarningsPerShareBasic`	$-13.00	USD	Annual
Weighted average shares outstanding, basic and diluted	`WeightedAverageNumberOfSharesOutstandingBasic`	1.45M	shares	Annual
Weighted average shares outstanding, basic and diluted	`WeightedAverageNumberOfSharesOutstandingBasic`	472,343.00	shares	Annual

Cash Flow Statement 84 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-18.47M	USD	Annual
Net loss	`NetIncomeLoss`	$-48.98M	USD	Annual
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	$-9.33M	USD	Annual
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	$-4.32M	USD	Annual
Change in fair value of investment option liability	`GainLossOnInvestments`	$3.47M	USD	Annual
Change in fair value of investment option liability	`GainLossOnInvestments`	-	USD	Annual
Change in fair value of derivative liability	`DerivativeGainLossOnDerivativeNet`	-	USD	Annual
Change in fair value of derivative liability	`DerivativeGainLossOnDerivativeNet`	$-325.00K	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$2.62M	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$12.60M	USD	Annual
Stock issued in lieu of cash for services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$33.47K	USD	Annual
Stock issued in lieu of cash for services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	-	USD	Annual
Impairment of intangible assets and goodwill	`GoodwillAndIntangibleAssetImpairment`	$7.45M	USD	Annual
Impairment of intangible assets and goodwill	`GoodwillAndIntangibleAssetImpairment`	$38.68M	USD	Annual
Non-cash income tax benefit	`NoncashIncomeTaxExpense`	$-1.50M	USD	Annual
Non-cash income tax benefit	`NoncashIncomeTaxExpense`	$-7.45M	USD	Annual
Inducement expense	`InducementExpense`	-	USD	Annual
Inducement expense	`InducementExpense`	$1.13M	USD	Annual
Amortization of right-of-use asset	`OperatingLeaseRightOfUseAssetAmortizationExpense`	$107.29K	USD	Annual
Amortization of right-of-use asset	`OperatingLeaseRightOfUseAssetAmortizationExpense`	$24.97K	USD	Annual
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$168.75K	USD	Annual
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$643.33K	USD	Annual
Depreciation expense	`Depreciation`	$13.31K	USD	Annual
Depreciation expense	`Depreciation`	$159.16K	USD	Annual
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$374.06K	USD	Annual
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-826.84K	USD	Annual
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$383.20K	USD	Annual
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$263.69K	USD	Annual
Right-of-use operating lease liability	`IncreaseDecreaseInRightOfUseOperatingLeaseLiability`	$-107.29K	USD	Annual
Right-of-use operating lease liability	`IncreaseDecreaseInRightOfUseOperatingLeaseLiability`	$-24.97K	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-17.15M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-11.46M	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$584.16K	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$189.72K	USD	Annual
Purchase of Diverse Bio license agreement	`PaymentsToAcquireIntangibleAssets`	-	USD	Annual
Purchase of Diverse Bio license agreement	`PaymentsToAcquireIntangibleAssets`	$675.00K	USD	Annual
Cash accretive acquisition of MagicMed	`CashAcquiredFromAcquisition`	$3.06M	USD	Annual
Cash accretive acquisition of MagicMed	`CashAcquiredFromAcquisition`	-	USD	Annual
Net cash (used in) provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$2.19M	USD	Annual
Net cash (used in) provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-584.16K	USD	Annual
Proceeds from sale of common stock, warrants, and investment options, net of offering costs	`ProceedsFromIssuanceOfCommonStock`	$17.22M	USD	Annual
Proceeds from sale of common stock, warrants, and investment options, net of offering costs	`ProceedsFromIssuanceOfCommonStock`	$21.61M	USD	Annual
Proceeds from the sale of redeemable non-controlling interest, net of offering costs (see Note 8)	`ProceedsFromMinorityShareholders`	-	USD	Annual
Proceeds from the sale of redeemable non-controlling interest, net of offering costs (see Note 8)	`ProceedsFromMinorityShareholders`	$958.04K	USD	Annual
Proceeds from warrant exercises, net of fees	`ProceedsFromWarrantExercises`	-	USD	Annual
Proceeds from warrant exercises, net of fees	`ProceedsFromWarrantExercises`	$3.29M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$24.90M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$18.18M	USD	Annual
Effect of foreign exchange rate on cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$-81.36K	USD	Annual
Effect of foreign exchange rate on cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$144.94K	USD	Annual
Net increase in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$367.88K	USD	Annual
Net increase in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$15.78M	USD	Annual
Cash at beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$1.58M	USD	Point-in-time
Cash at beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$17.36M	USD	Point-in-time
Cash at beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$17.72M	USD	Point-in-time
Cash at end of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$1.58M	USD	Point-in-time
Cash at end of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$17.36M	USD	Point-in-time
Cash at end of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$17.72M	USD	Point-in-time
Cash paid for interest	`InterestPaidNet`	$5.25K	USD	Annual
Cash paid for interest	`InterestPaidNet`	$10.32K	USD	Annual
Income taxes paid	`IncomeTaxesPaidNet`	-	USD	Annual
Income taxes paid	`IncomeTaxesPaidNet`	-	USD	Annual
Investment options issued in conjunction with common stock issuance	`InvestmentOptionsIssuedInConjunctionWithCommonStockIssuance`	$4.32M	USD	Annual
Investment options issued in conjunction with common stock issuance	`InvestmentOptionsIssuedInConjunctionWithCommonStockIssuance`	-	USD	Annual
Modification of warrants as part of share capital raise	`ModificationOfWarrantsAsPartOfShareCapitalRaise`	-	USD	Annual
Modification of warrants as part of share capital raise	`ModificationOfWarrantsAsPartOfShareCapitalRaise`	$251.36K	USD	Annual
Warrants issued in conjunction with common stock issuance	`WarrantsIssuedInConjunctionWithNotesPayable`	$3.60M	USD	Annual
Warrants issued in conjunction with common stock issuance	`WarrantsIssuedInConjunctionWithNotesPayable`	-	USD	Annual
Issuance of embedded derivative	`IssuanceOfEmbeddedDerivative`	$402.00K	USD	Annual
Issuance of embedded derivative	`IssuanceOfEmbeddedDerivative`	-	USD	Annual
Preferred dividends attributable to redeemable non-controlling interest	`PreferredDividendsAttributableToRedeemableNoncontrollingInterest`	-	USD	Annual
Preferred dividends attributable to redeemable non-controlling interest	`PreferredDividendsAttributableToRedeemableNoncontrollingInterest`	$33.01K	USD	Annual
Accretion of embedded derivative to redemption value	`AccretionOfEmbeddedDerivativeToRedemptionValue`	$295.98K	USD	Annual
Accretion of embedded derivative to redemption value	`AccretionOfEmbeddedDerivativeToRedemptionValue`	-	USD	Annual
Issuance of Common Stock pursuant to MagicMed amalgamation	`StockIssued1`	$39.04M	USD	Annual
Issuance of Common Stock pursuant to MagicMed amalgamation	`StockIssued1`	-	USD	Annual
Deferred tax liability incurred due to MagicMed amalgamation	`DeferredTaxLiabilityIncurredDueToAmalgamation`	-	USD	Annual
Deferred tax liability incurred due to MagicMed amalgamation	`DeferredTaxLiabilityIncurredDueToAmalgamation`	$9.06M	USD	Annual
Conversion of preferred stock to common stock	`ConversionOfPreferredStockToCommonStock`	$32.75K	USD	Annual
Conversion of preferred stock to common stock	`ConversionOfPreferredStockToCommonStock`	-	USD	Annual
Fair value of warrants issued	`FairValueOfWarrantsIssued`	-	USD	Annual
Fair value of warrants issued	`FairValueOfWarrantsIssued`	$9.98M	USD	Annual
Right-of-use assets obtained in exchange for lease liabilities	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	-	USD	Annual
Right-of-use assets obtained in exchange for lease liabilities	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	$201.65K	USD	Annual

Stockholders Equity 38 line items

Line Item	Tag	Value	Unit	Period
Issuance of embedded derivative	`IssuanceOfEmbeddedDerivative`	$402.00K	USD	Annual
Issuance of embedded derivative	`IssuanceOfEmbeddedDerivative`	-	USD	Annual
Redeemable noncontrolling interest issuance costs	`RedeemableNoncontrollingInterestIssuanceCosts`	$41.96K	USD	Annual
Beginning balance, value	`StockholdersEquity`	$22.31M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$3.42M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$14.67M	USD	Point-in-time
January 2021 registered direct offering, net of offering costs	`StockIssuedDuringPeriodValueIssuedDirectOfferingNetOfOfferingCostOne`	$4.62M	USD	Annual
February 2021 registered direct offering, net of offering costs	`StockIssuedDuringPeriodValueIssuedDirectOfferingNetOfOfferingCostTwo`	$7.02M	USD	Annual
Consideration paid pursuant to amalgamation agreement	`ConsiderationPaidPursuantToAmalgamationAgreement`	$39.04M	USD	Annual
Exercise of warrants	`StockIssuedDuringPeriodValueWarrantsExercised`	$3.29M	USD	Annual
Exercise of options	`StockIssuedDuringPeriodValueStockOptionsExercised`	-	USD	Annual
Exercise of options, shares	`StockIssuedDuringPeriodSharesStockOptionsExercised`	2,876.00	shares	Annual
Induced conversion of stock options into restricted stock awards	`StockIssuedDuringPeriodValueInducedConversionOfStockOptionsIntoRestrictedStockAwards`	$1.13M	USD	Annual
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$2.62M	USD	Annual
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$12.60M	USD	Annual
Common stock issued in lieu of cash for services	`StockIssuedDuringPeriodValueIssuedForServices`	$33.47K	USD	Annual
Common stock issued pursuant to exercise of warrant put rights	`StockIssuedDuringPeriodValueIssuedPursuantExerciseOfWarrant`	-	USD	Annual
Conversion of Series B preferred shares	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	-	USD	Annual
Foreign exchange translation loss	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$150.47K	USD	Annual
Foreign exchange translation loss	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-505.93K	USD	Annual
Net loss	`NetIncomeLoss`	$-18.47M	USD	Annual
Net loss	`NetIncomeLoss`	$-48.98M	USD	Annual
February 2022 registered direct offering, net of offering costs	`StockIssuedDuringPeriodValueIssuedDirectOfferingNetOfOfferingCostThree`	$5.80M	USD	Annual
Conversion of RSUs into common shares	`StockIssuedDuringPeriodValueRestrictedStockAwardGross`	-	USD	Annual
Redeemable non-controlling interest, net of $402,000 embedded derivative and net of issuance costs of $41,962	`RedeemableNoncontrollingInterestEmbeddedDerivativeAndNetOfIssuanceCosts`	-	USD	Annual
Redeemable noncontrolling interest, net of $402,000 embedded derivative and net of issuance costs of $41,962, shares	`RedeemableNoncontrollingInterestEmbeddedDerivativeAndNetOfIssuanceCostsShares`	556,038.00	shares	Annual
Issuance of redeemable Series C preferred stock	`IssuanceOfRedeemableNoncontrollingSeriesPreferredStock`	$-527.00	USD	Annual
Preferred dividends attributable to redeemable non-controlling interest	`PreferredDividendsAttributableToRedeemableNoncontrollingInterest`	-	USD	Annual
Preferred dividends attributable to redeemable non-controlling interest	`PreferredDividendsAttributableToRedeemableNoncontrollingInterest`	$33.01K	USD	Annual
Accretion of embedded derivative to redemption value	`AccretionOfEmbeddedDerivativeToRedemptionValue`	$295.98K	USD	Annual
Accretion of embedded derivative to redemption value	`AccretionOfEmbeddedDerivativeToRedemptionValue`	-	USD	Annual
Conversion of RSAs into common shares	`StockIssuedDuringPeriodValueConversionOfUnits`	-	USD	Annual
July 2022 registered direct offering, PIPE offering, modification of warrants and exercise of pre-funded warrants, net of offering costs	`RegisteredDirectOfferingPipeOfferingModificationOfWarrantsAndExerciseOfPrefundedWarrantsNetOfOfferingCosts`	$3.25M	USD	Annual
Issuance of rounded shares as a result of the reverse stock split	`IssuanceOfRoundedSharesAsResultOfReverseStockSplit`	-	USD	Annual
Redemption of Series C preferred stock	`StockRedeemedOrCalledDuringPeriodValue`	$527.00	USD	Annual
Ending balance, value	`StockholdersEquity`	$22.31M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$3.42M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$14.67M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.